Ponalid in the treatment of non-chemical parkinsonism: a souble-blind study with nine months' follow-up.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D006801:Humans; D008875:Middle Aged; D009662:Nortropanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000009:adverse effects / Q000188:drug therapy / Q000601:surgery*; D010300:Parkinson Disease / Q000627:therapeutic use*
D009662:Nortropanes; D010276:Parasympatholytics